Literature DB >> 8386141

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

C K Sam1, L A Brooks, G Niedobitek, L S Young, U Prasad, A B Rickinson.   

Abstract

Although Epstein-Barr virus (EBV) is consistently associated with the epithelial malignancy nasopharyngeal carcinoma (NPC), it is not clear to what extent the normal virus carrier state involves infection of nasopharyngeal epithelium. We attempted to examine this question by screening 26 nasopharyngeal punch biopsies from EBV-carrying Chinese Malaysians who had presented with clinical symptoms possibly indicative of NPC, but in whom histological analysis of an adjacent biopsy had revealed no evidence of tumour. Assays included (i) in situ hybridization with 35S-labelled riboprobes specific for EBERs (rather than with BamHI W DNA probes which can give false-positive results); (ii) cDNA amplification across defined splice junctions of the EBNA1 and BamHI A transcripts expressed in latently-infected NPC cells and of the BHRF1 lytic-cycle transcript; and (iii) immunostaining for the immediate early lytic-cycle protein BZLF1. Of the 26 biopsies examined, all 23 showing normal nasopharyngeal histology were consistently negative for both latent and lytic-cycle markers. The other 3 cases were all positive for EBNA1 and BamHI A transcripts; these RNAs were almost certainly of tumour rather than normal-cell origin since these particular biopsies were the only ones to reveal localized foci of EBER-positive NPC cells; such biopsies were again negative for lytic-cycle markers. We provisionally conclude that EBV infection of the normal nasopharynx is not a regular feature of the virus carrier state and that screening nasopharyngeal biopsies for viral RNA markers of the latent cycle could be useful in NPC diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386141     DOI: 10.1002/ijc.2910530616

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  G Niedobitek
Journal:  Mol Pathol       Date:  2000-10

3.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

Review 4.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 5.  The Epstein-Barr virus and its association with human cancers.

Authors:  K R Baumforth; L S Young; K J Flavell; C Constandinou; P G Murray
Journal:  Mol Pathol       Date:  1999-12

6.  Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.

Authors:  S Bulfone-Paus; L A Dempsey; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

Review 7.  Circulating free xeno-microRNAs - The new kids on the block.

Authors:  Linda Fabris; George Adrian Calin
Journal:  Mol Oncol       Date:  2016-01-21       Impact factor: 6.603

Review 8.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 9.  The role of miRNAs and EBV BARTs in NPC.

Authors:  Aron R Marquitz; Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2011-12-10       Impact factor: 15.707

Review 10.  The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers.

Authors:  Paolo De Paoli; Chiara Pratesi; Maria Teresa Bortolin
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.